Cargando…
Management of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis
Systemic sclerosis (SSc) is a rare and complex immune-mediated connective tissue disease characterized by multi-organ fibrosis and dysfunction. Systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH) is a leading cause of death in this population. Pulmonary arterial hypertension (PAH...
Autores principales: | Almaaitah, Saja, Highland, Kristin B, Tonelli, Adriano R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125406/ https://www.ncbi.nlm.nih.gov/pubmed/32280271 http://dx.doi.org/10.2147/IBPC.S232038 |
Ejemplares similares
-
Novel Treatment Pathways in Pulmonary Arterial Hypertension
por: Qaiser, Kanza N., et al.
Publicado: (2021) -
Screening for pulmonary arterial hypertension in systemic sclerosis
por: Weatherald, Jason, et al.
Publicado: (2019) -
Baseline history of patients using selexipag for pulmonary arterial
hypertension
por: Highland, Kristin B., et al.
Publicado: (2019) -
Palliative care in pulmonary arterial hypertension: an underutilised treatment
por: Khirfan, Ghaleb, et al.
Publicado: (2018) -
Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Perioperative management in patients with pulmonary hypertension
por: Tonelli, Adriano R., et al.
Publicado: (2014)